Recommendations for the use of Lyme disease vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) [corrected] [published erratum appears in MMWR MORB MORTAL WKLY REP 1999 Sep 24; 48(37): 833].
This report provides recommendations for use of a newly developed recombinant outer-surface protein A (rOspA) Lyme disease vaccine (LYMErix,[TM] SmithKline Beecham Pharmaceuticals) for persons aged 15-70 years in the United States. The purpose of these recommendations is to provide health-care provi...
| Published in: | MMWR: Morbidity & Mortality Weekly Report Vol. 48; no. 21; pp. 1 - 26 |
|---|---|
| Format: | CEU exam questions practice guidelines tables/charts Journal Article |
| Published: |
Centers for Disease Control & Prevention (CDC)
6/4/1999
|
| Online Access: | View this record in EBSCOhost |